retatrutide news october 2025 A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Lilly's Retatrutide Scores Triple Trial

Description

5,10,14 Psoriasis, an autoimmune inflammatory skin condition, was shown to resolve in patients with obesity who underwent bariatric surgery, thus linking this disorder to increased adiposity

Products like Ozempic and Wegovy are GLP-1 drugs, named after the hormone they mimic and which is activated by food intake

Pak J Med Sci

The above figures are based on data compiled from multiple Irish pharmacies (including online sources) in late 2024 actual prices may vary slightly by pharmacy and over time

All available safety information derives from regulated clinical trials conducted under investigational new drug frameworks, primarily sponsored by Eli Lilly and Company